Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin C
The UKCCCR Anal Cancer Trial Working Party
The UKCCCR Anal Cancer Trial Working Party Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin C Lancet 348 1996 1049-1054
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomised trial of the European organisation for research and treatment of cancer radiotherapy and gastrointestinal groups
H. Bartelink F. Roelofson F. Eschwege et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomised trial of the European organisation for research and treatment of cancer radiotherapy and gastrointestinal groups J Clin Oncol 15 1997 2040-2049
Role of mitomycin in combination with fluorouracil and radiation and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomised intergroup study
M. Flam M. John T.F. Pajak et al. Role of mitomycin in combination with fluorouracil and radiation and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomised intergroup study J Clin Oncol 14 1996 2527-2539
Radical chemoradiation for squamous cell carcinoma of the anus using a two phase technique with no boost
A. Melcher C. Brammer D. Sebag-Montefiore Radical chemoradiation for squamous cell carcinoma of the anus using a two phase technique with no boost Br J Cancer 85 Suppl 2001 103
Chemoradiation and maintenance chemotherapy for patients with anal carcinoma: A phase II trial of the UK coordinating committee for cancer research (UKCCCR) anal cancer working party
[abstract 1045]
R.D. James D. Cunningham N. Davidson et al. Chemoradiation and maintenance chemotherapy for patients with anal carcinoma: A phase II trial of the UK coordinating committee for cancer research (UKCCCR) anal cancer working party Proceedings of ASCO 19 2000 [abstract 1045]
The second UK phase III anal cancer trial of chemoradiation and maintenance therapy (ACT II): Preliminary results on toxicity and outcome
for the NCRI Anal Cancer Trials Management Group [abstract 1151]
R. James H. Meadows for the NCRI Anal Cancer Trials Management Group The second UK phase III anal cancer trial of chemoradiation and maintenance therapy (ACT II): Preliminary results on toxicity and outcome Proceedings of ASCO 22 2003 [abstract 1151]
Effective treatment of anal cancer in the elderly with low dose chemoradiotherapy
N. Charnley A. Choudhury P. Chesser R.A. Cooper D. Sebag-Montefiore Effective treatment of anal cancer in the elderly with low dose chemoradiotherapy Br J Cancer 92 2005 1221-1225
The role of biological molecular markers in predicting both response to treatment and clinical outcome in squamous cell carcinoma of the anus
[abstract 183] Anal Cancer Trial Management Group
S. Mawdsley Anal Cancer Trial Management Group H. Meadows R. James The role of biological molecular markers in predicting both response to treatment and clinical outcome in squamous cell carcinoma of the anus ASCO 2004 [abstract 183]
